Search research articles
Contact Us
Filters
Showing results (851-860 of 1,095) with videos related to
Page
of 110
Sort By:
Clinical Genitourinary Cancer
|
January 10, 2022
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study
Daniele Raggi, Patrizia Giannatempo, Laura Marandino, et al.
Targeted Oncology
|
July 17, 2020
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis
Roberto Iacovelli, Chiara Ciccarese, Gaetano Facchini, et al.
Alimentary Pharmacology & Therapeutics
|
February 8, 2024
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury
Mar Riveiro-Barciela, Ana Barreira-Díaz, María-Teresa Salcedo, et al.
Digestive Diseases and Sciences
|
October 17, 2018
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Clinical & Experimental Metastasis
|
September 6, 2025
Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset
Alessandro Rizzo, Anas Zayed, Elsa Vitale, et al.
Hepatology (Baltimore, Md.)
|
August 12, 2020
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase
Josef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Expert Review of Anticancer Therapy
|
April 5, 2023
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?
Matilde Corianò, Diana Giannarelli, Giulia Scartabellati, et al.
Gut
|
July 12, 2014
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
Pauline Arends, Milan J Sonneveld, Roeland Zoutendijk, et al.
Nature Communications
|
February 1, 2018
RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73
Angelos Papaspyropoulos, Leanne Bradley, Asmita Thapa, et al.
Gastroenterologia Y Hepatologia
|
October 18, 2022
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction
Javier Crespo, Joaquín Cabezas, Antonio Aguilera, et al.
Page
of 110
Search research articles
Search
Showing results (851-860 of 1,095) with videos related to
Sort By:
Page
of 110
Clinical Genitourinary Cancer
|
January 10, 2022
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study
Daniele Raggi, Patrizia Giannatempo, Laura Marandino, et al.
Targeted Oncology
|
July 17, 2020
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis
Roberto Iacovelli, Chiara Ciccarese, Gaetano Facchini, et al.
Alimentary Pharmacology & Therapeutics
|
February 8, 2024
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury
Mar Riveiro-Barciela, Ana Barreira-Díaz, María-Teresa Salcedo, et al.
Digestive Diseases and Sciences
|
October 17, 2018
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Clinical & Experimental Metastasis
|
September 6, 2025
Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset
Alessandro Rizzo, Anas Zayed, Elsa Vitale, et al.
Hepatology (Baltimore, Md.)
|
August 12, 2020
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase
Josef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Expert Review of Anticancer Therapy
|
April 5, 2023
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?
Matilde Corianò, Diana Giannarelli, Giulia Scartabellati, et al.
Gut
|
July 12, 2014
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
Pauline Arends, Milan J Sonneveld, Roeland Zoutendijk, et al.
Nature Communications
|
February 1, 2018
RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73
Angelos Papaspyropoulos, Leanne Bradley, Asmita Thapa, et al.
Gastroenterologia Y Hepatologia
|
October 18, 2022
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction
Javier Crespo, Joaquín Cabezas, Antonio Aguilera, et al.
Page
of 110